Relay Therapeutics, Inc. 4

SoftBank Vision Fund–affiliated entity SVF Pauling (Cayman) Ltd. sold 6,000,000 shares of Relay Therapeutics, Inc. common stock at $19.40 per share on August 25, 2026.

On August 25, 2026, SVF Pauling (Cayman) Ltd., an investment vehicle affiliated with SoftBank Vision Fund (AIV M2) L.P. and managed by SB Investment Advisers (UK) Ltd., reported the open-market sale of 6,000,000 shares of Relay Therapeutics, Inc. common stock at a price of $19.40 per share, for total proceeds of approximately $116.4 million. Following this disposition, the reporting group continued to hold 21,904,963 shares indirectly, reflecting that the transaction was a sizable portfolio-level sell-down by a financial sponsor rather than an insider’s personal liquidity event, and SB Investment Advisers (UK) Ltd. was identified as the AIFM with exclusive responsibility for investment decisions regarding these holdings.

Filing Facts

CIK

1812364

Ticker

RLAY

Form

4

Source Type

fda

Accession

0001493152-26-040513

Alert Tier

7